Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: Results of an international survey among members of the European Thyroid Association

Clinical Endocrinology

Volumn 61, Issue 4, 2004, Pages 494-502

  Bartalena, Luigi ^a   Wiersinga, Wilmar M ^b   Tanda, Maria Laura ^a   Bogazzi, Fausto ^c   Piantanida, Eliana ^a   Lai, Adriana ^a   Martino, Enio ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Academic Clinical Center   (Netherlands)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOCORTICOID; IODINE; LIOTHYRONINE; POTASSIUM PERCHLORATE; RADIOACTIVE IODINE; THIONAMIDE DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNITY; BRAZIL; CASE REPORT; CHRONIC DRUG ADMINISTRATION; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC PROCEDURE; DRUG WITHDRAWAL; EUROPE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEALTH SURVEY; HUMAN; HYPOTHYROIDISM; MALE; MEDICAL SOCIETY; NODULAR GOITER; PRIORITY JOURNAL; THYROID FUNCTION; THYROID SCINTISCANNING; THYROTOXICOSIS; TREATMENT INDICATION; ULTRASOUND; UNITED STATES; URINARY EXCRETION;

AMIODARONE; EUROPE; HUMANS; IODINE RADIOISOTOPES; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; THYROID FUNCTION TESTS; THYROID GLAND; THYROID HORMONES; THYROIDECTOMY; THYROTOXICOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR; VASODILATOR AGENTS;

EID: 6344244734     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02119.x     Document Type: Article

References (29)

1. Bartalena, L. (2003) The dilemma of non-thyroidal illness: to treat or not to treat? Journal of Endocrinological Investigation, 26, 1162.
2. Bartalena, L., Grasso, L., Brogioni, S., Mazzeo, S., Aghini-Lombardi, R, Braverman, L.E. & Martine, E. (1994) Serum interleukin-6 in amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 78, 423-427.
3. Bartalena, L., Brogioni, S., Grasso, L., Bogazzi, F., Burelli, A. & Martino, E. (1996) Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. Journal of Clinical Endocrinology and Metabolism, 81, 2930-2933.
4. Bartalena, L., Bogazzi, F. & Martino, E. (2002) Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge. Clinical Endocrinology, 56, 23-24.
5. Bogazzi, F., Bartalena, L., Gasperi, M., Braverman, L.E. & Martino, E. (2001) The various effects of amiodarone on thyroid function. Thyroid, 11, 511-519.
6. Bogazzi, E, Aghini-Lombardi, F., Cosci, C., Lupi, I., Santini, F., Tanda, M.L., Miccoli, P., Basolo, F., Pinchera, A., Bartalena, L., Braverman, L.E. & Martino, E. (2002) Iopanoic acid rapidly controls type I amiodarone-induced thyrotoxicosis prior to thyroidectomy. Journal of Endocrinological Investigation, 26, 176-180.
7. Bogazzi, F., Bartalena, L., Cosci, C., Brogioni, S., Dell'Unto, E., Grasso, L., Aghini-Lombardi, F., Rossi, G., Pinchera, A., Braverman, L.E. & Martino, E. (2003a) Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study. Journal of Clinical Endocrinology and Metabolism, 88, 1999-2002.
8. Bogazzi, F., Martine, E., Dell'Unto, E., Brogioni, S., Cosci, C., Aghini-Lombardi, F., Ceccarelli, C., Pinchera, A., Bartalena, L. & Braverman, L.E. (2003b) Thyroid color flow Doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. Journal of Endocrinological Investigation, 26, 635-640.
9. Braga, M. & Cooper, D.S. (2001) Oral cholecystographic agents and the thyroid. Journal of Clinical Endocrinology and Metabolism, 86, 1853-1860.
10. Chopra, I.J. & Baber, K. (2001) Use of oral cholecystographic agents in the treatment of amiodarone-induced hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 86, 4707-4710.
11. Daniels, G.H. (2001) Amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 86, 3-7.
12. Davies, P.H., Franklyn, J.A. & Sheppard, M.C. (1992) Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. British Medical Journal, 305, 224-225.
13. Eaton, S.E.M., Euinton, H.A., Newman, C.M., Weetman, A.P. & Bennet, W.M. (2002) Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clinical Endocrinology, 56, 33-38.
14. Erdogan, M.F., Gulec, S., Tutar, E., Baskal, N. & Erdogan, G. (2003) A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid, 13, 205-209.
15. Farwell, A.P., Abend, S.L., Huang, S.K.S., Patwardhan, N.A. & Braverman, L.E. (1990) Thyroidectomy for amiodarone-induced thyrotoxicosis. Journal of American Medical Association, 263, 1526-1528.
16. Harjai, K.J. & Licata, A. A. (1997) Effects of amiodarone on thyroid function. Annals of International Medicine, 126, 63-73.
17. Martino, E., Aghini-Lombardi, F., Mariotti, S., Lenziardi, M., Baschieri, L., Braverman, L.E. & Pinchera, A. (1986) Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. Journal of Endocrinological Investigation, 9, 201-207.
18. Martino, E., Safran, M., Aghini-Lombardi, F., Rajatanavin, R., Lenziardi, M., Fay, M., Pacchiarotti, A., Aronin, A., Macchia, E., Haffajee, C., Baschieri, L., Pinchera, A. & Braverman, L.E. (1984) Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Annals of Internal Medicine, 101, 28-34.
19. Martino, E., Bartalena, L., Bogazzi, F. & Braverman, L.E. (2001) The effects of amiodarone on the thyroid. Endocrine Reviews, 22, 240-254.
20. Newman, C.M., Price, A., Davies, D.W., Gray, T.A. & Weetman, A.P. (1998) Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart, 79, 121-127.
21. Osman, F., Franklyn, J.A., Sheppard, M.C. & Gammage, M.D. (2002) Successful treatment of amiodarone-induced thyrotoxicosis. Circulation, 105, 1275-1277.
22. Pearce, E.N., Bogazzi, F., Martino, E., Brogioni, S., Pardini, E., Pellegrini, G., Parkes, A.B., Lazarus, J.H., Pinchera, A. & Braverman, L.E. (2003) The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid, 13, 643-648.
23. Roti, E., Minelli, R., Gardini, E., Bianconi, L., Gavaruzzi, G., Ugonotti, G., Neri, T.M. & Braverman, L.E. (1992) Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 75, 1273-1277.
24. Roti, E., Minelli, R., Gardini, E., Bianconi, L. & Braverman, L.E. (1993) Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. Archives of International Medicine, 153, 886-892.
25. Ryan, L.E., Braverman, L.E., Cooper, D.S., Ladenson, P. W. & Kloos, R.T. (2004) Can amiodarone be restarted after amiodarone-induced thyrotoxicosis? Thyroid, 14, 149-153.
26. Trip, M.D., Duren, D.R. & Wiersinga, W.M. (1994) Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued. British Heart Journal, 73, 266-268.
27. Trip, M.D., Wiersinga, W.M. & Plomp, T.A. (1991) Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. American Journal of Medicine, 91, 507-511.
28. Wiersinga, W.M. (1997) Amiodarone and the thyroid. In: Pharmacotherapeutics of the Thyroid Gland (eds A. P. Weetman & A. Grossman), pp. 225-287. Springer Verlag, Berlin.
29. Williams, M. & Lo Gerfo, P. (2002) Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. Thyroid, 12, 523-525.